HRAS‐driven cancer cells are vulnerable to TRPML1 inhibition
暂无分享，去创建一个
A. Naji | Dharini van der Hoeven | Hong Liang | Yong Zhou | Kwang-jin Cho | J. Hancock | A. Sikora | Ching-On Wong | K. Venkatachalam | I. Levental | Nicholas E. Karagas | Jewon Jung | Mariana Villanueva | L. Tan | S. Gregory | Kristen Clemons | Morgan A. Rousseau | K. Tomasevich | Kelly M. Tomasevich | Kelly M. Tomasevich